Company research / MRMD

Marimed Inc. (MRMD)

SEC name MARIMED INC. · CIK 0001522767 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Marimed Inc. reported revenue of $159.83M. Revenue grew 1.3% from the prior annual period.

Key ratios (year ended 2025-12-31)

36.2%
Gross margin
-1.8%
Operating margin
-9.1%
Net margin
-29.0%
Return on year-end equity
1.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$159.83M$157.71M$148.60M$134.01M$121.46M$50.90M$45.60M$11.85M$6.07M$3.56M
Cost of Revenue$101.94M$95.10M$82.68M$70.05M$55.20M$19.57M$26.90M$4.04M$2.19M$1.35M
Gross Profit$57.88M$62.61M$65.92M$63.96M$66.26M$31.32M$18.70M$7.81M$3.88M$1.95M
Operating Income-$2.82M$2.61M$14.38M$20.37M$26.86M$14.53M-$41.53M-$5.36M$127.7K$775.3K
Depreciation & Amortization$8.11M$7.91M$5.55M$3.43Mn/a$1.80M$1.00M$658.0K$363.0K$265.7K
EBITDA$5.29M$10.52M$19.93M$23.80Mn/a$16.33M-$40.53M-$4.70M$490.6K$1.04M
Net Income-$14.48M-$12.47M-$16.03M$13.47M$7.22M$2.14M-$81.18M-$13.60M-$1.19M-$198.9K
EPS (Diluted)-$0.04-$0.03-$0.04$0.04$0.02$0.01-$0.39n/an/an/a
Total Assets$202.56M$206.99M$196.12M$152.20M$123.20M$76.45M$61.57M$82.96M$32.20M$8.56M
Total Liabilities$137.83M$129.44M$107.21M$57.17M$49.18M$53.62M$55.24M$21.20M$21.19M$9.11M
Long-Term Debt$76.04M$78.19Mn/an/an/a$36.71M$36.28M$14.97Mn/an/a
Shareholders' Equity$50.01M$58.55M$69.91M$57.31M$36.30M$8.10M$6.33M$61.76M$11.01M-$551.4K
Cash & Equivalentsn/a$7.28M$14.64M$9.74M$29.68M$3.00M$738.7K$4.10M$1.29M$569.4K
Operating Cash Flow$7.70M$6.79M$7.91M$7.31M$35.85M$3.38M-$24.14M-$2.91M$1.76M-$197.9K
Capital Expenditures$1.17M$11.96M$20.13M$12.14M$17.87M$4.69M$9.67M$8.92M$20.98M$3.36M
Free Cash Flow$6.53M-$5.17M-$12.22M-$4.83M$17.98M-$1.31M-$33.81M-$11.83M-$19.21M-$3.56M
Shares Outstanding396.91M381.48M375.13M341.47M334.03M314.42M228.41M211.01M176.85M64.07M
Weighted Average Diluted Shares390.13M379.15M363.40M380.29M372.40M324.16M208.72Mn/an/an/a
EPS (Basic)-$0.04-$0.03-$0.04$0.04$0.02$0.01-$0.39n/an/an/a